DRUG Dividend History & Analysis | N/A Yield
DRUG has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| ABBV | 387,093 M | 3.34% | 7.54% |
| AMGN | 198,244 M | 3.21% | 5.93% |
| GILD | 176,133 M | 2.79% | 5.63% |
| HLN | 46,623 M | 1.76% | 2.46% |
| BIM | 13,627 M | 0.74% | 0.75% |
| Symbol | Market Cap USD | Growth Rate | Consistency |
|---|---|---|---|
| BTX | 1,425 M | 134% | 95.6% |
| HLN | 46,623 M | 30.1% | 100% |
| AMGN | 198,244 M | 7.84% | 100% |
| BIM | 13,627 M | 9.76% | 96.0% |
| ABBV | 387,093 M | 5.98% | 100% |
Quality Dividend Peers in Biotechnology
3.21% Yield
2.79% Yield
DRUG Dividend History: as of February 2026
No dividends paid yet.DRUG Dividend FAQ
Bright Minds Biosciences Inc. (NASDAQ: DRUG) is a U.S.-based biotech focused on selective 5-HT receptor agonists for severe neurological and neuropsychiatric disorders. Its pipeline includes 5-HT2C, 5-HT2A, and combined 5-HT2C/A programs targeting epilepsy, pain, and neuropsychiatry, plus BMB-101 (phase 1 completed for an undisclosed seizure disorder) and BMB-201/202 for broader neuro-psychiatric and neurology indications. The firm leverages collaborations with the National Institutes of Health, the University of Texas Medical Branch, and the Medical College of Wisconsin, and has operated since its 2017 founding out of New York.
What is the Dividend Yield of DRUG?
As of February 2026, DRUG`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 75.97.Does DRUG pay a dividend?
As of February 2026 DRUG does not pay a dividend.How often does DRUG pay dividends?
Over the last 12 months, DRUG has issued dividend payments.DRUG dividend forecast
Based on historical data, the forecasted dividends per share for DRUG for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will DRUG pay dividends in 2026?
The next Ex-Dividend date for Bright Minds Biosciences (DRUG) is currently unknown.What is the next Ex-Dividend Date for DRUG?
The next Ex-Dividend date for Bright Minds Biosciences (DRUG) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of DRUG?
DRUG's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of DRUG?
DRUG's 5-Year Yield on Cost is -%. If you bought DRUG's shares at 27.00 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of DRUG?
DRUG Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does DRUG have a good Dividend Yield?
DRUG`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of DRUG?
The Dividend Payout Ratio of DRUG is unknown.What is the Dividend Rating of DRUG?
DRUG`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield
- Annual dividend per share divided by current share price.
- Payout Ratio
- Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
- Payout FCF
- Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
- Growth Rate (CAGR)
- Compound annual growth rate of dividends over the last 5 years.
- Consistency
- Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
- Yield on Cost
- Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
- Streak
- Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
- Dividend Rating
- Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-01-30 14:22